Status:
COMPLETED
Antioxidant Treatment of Type 2 Diabetes
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Eligibility Criteria
Inclusion
- Subjects with a known diagnosis of type 2 diabetes -
Exclusion
- None, except known intolerance to n-acetylcysteine
- \-
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00609102
Start Date
July 1 2008
End Date
September 1 2013
Last Update
December 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacific Northwest Research Institute
Seattle, Washington, United States, 98122